1. Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC – The ETOP/EORTC SPLENDOUR and AMGEN-249 trials. (November 2021) Authors: Peters, Solange; Danson, Sarah; Ejedepang, Dunson; Dafni, Urania; Hasan, Baktiar; Radcliffe, Hoi-Shen; Bustin, Frederique; Crequit, Jacky; Coate, Linda; Guillot, Monica; Surmont, Veerle; Rauch, Daniel; Rudzki, Jakob; O'Mahony, Deirdre; Barneto Aranda, Isidoro; Scherz, Amina; Tsourti, Zoi; Roschit... Journal: Lung cancer Issue: Volume 161(2021) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion. (December 2019) Authors: Hendriks, Lizza E.L.; Dooms, Christophe; Berghmans, Thierry; Novello, Silvia; Levy, Antonin; De Ruysscher, Dirk; Hasan, Baktiar; Giaj Levra, Matteo; Giaj Levra, Niccolo; Besse, Benjamin; Vansteenkiste, Johan; Dingemans, Anne-Marie C. Journal: European journal of cancer Issue: Volume 123(2019) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey. (April 2018) Authors: Levy, Antonin; Faivre-Finn, Corinne; Hasan, Baktiar; De Maio, Eleonora; Berghoff, Anna S.; Girard, Nicolas; Greillier, Laurent; Lantuéjoul, Sylvie; O'Brien, Mary; Reck, Martin; Dingemans, Anne-Marie C.; Novello, Silvia; Berghmans, Thierry; Besse, Benjamin; Hendriks, Lizza Journal: European journal of cancer Issue: Volume 93(2018) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease. (November 2019) Authors: Levy, Antonin; Hendriks, Lizza E.L.; Berghmans, Thierry; Faivre-Finn, Corinne; GiajLevra, Matteo; GiajLevra, Niccolò; Hasan, Baktiar; Pochesci, Alessia; Girard, Nicolas; Greillier, Laurent; Lantuéjoul, Sylvie; Edwards, John; O'Brien, Mary; Reck, Martin; Besse, Benjamin; Novello, Silvia; Dingemans... Journal: European journal of cancer Issue: Volume 122(2019) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064). Issue 12 (August 2015) Authors: O'Brien, Mary E.R.; Gaafar, Rabab; Hasan, Baktiar; Menis, Jessica; Cufer, Tanja; Popat, Sanjay; Woll, Penella J.; Surmont, Veerle; Georgoulias, Vassilis; Montes, Ana; Blackhall, Fiona; Hennig, Ivo; Schmid-Bindert, Gerald; Baas, Paul; EORTC-LCG Journal: European journal of cancer Issue: Volume 51:Issue 12(2015:Aug.) Page Start: 1511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sample size computation in phase II designs combining the A'Hern design and the Sargent and Goldberg design. Issue 2 (3rd March 2020) Authors: Neven, Anouk; Mauer, Murielle; Hasan, Baktiar; Sylvester, Richard; Collette, Laurence Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 2(2020) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sample size computation in phase II designs combining the A'Hern design and the Sargent and Goldberg design. Issue 2 (3rd March 2020) Authors: Neven, Anouk; Mauer, Murielle; Hasan, Baktiar; Sylvester, Richard; Collette, Laurence Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 2(2020) Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061). (February 2016) Authors: Abdelraouf, Fatma; Smit, Egbert; Hasan, Baktiar; Menis, Jessica; Popat, Sanjay; van Meerbeeck, Jan P.; Surmont, Veerle F.; Baas, Paul; O'Brien, Mary Journal: European journal of cancer Issue: Volume 54(2016) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: A single-arm phase II study (EORTC-08061). (February 2016) Authors: Abdelraouf, Fatma; Smit, Egbert; Hasan, Baktiar; Menis, Jessica; Popat, Sanjay; van Meerbeeck, Jan P.; Surmont, Veerle F.; Baas, Paul; O'Brien, Mary Journal: European journal of cancer Issue: Volume 54(2016) Page Start: 35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗